biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Saltarelli is in the catbird seat...

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jan 10, 2023 11:53am

83 Views

Post# 35213546

RE:RE:RE:RE:RE:RE:Saltarelli is in the catbird seat...

you continue to bring up the ridiculous and absurd excuse that the biotech market has been horrific lately. that does not excuse the lack of progress by this company for so, so many years. nothing in the clinic. you also fail to mention several years ago we had one of the biggest biotech booms ever. why did this company faulter then? you're just absurd

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"